Performance analysis of Atossa Therapeutics (ATOS)
Annual Return
Over the past 3 years, ATOS has had an average annual return of -46.48%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, ATOS has had an average annual return of -47.06%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, ATOS has had an average annual return of -43.34%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Nov 8, 2012, ATOS has had an average annual return of -46.28%, underperforming the benchmark SPY, which returned +15.11% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -71.43% | -36.36% | +10% | +66.67% | -68.42% | +72.73% | -38.89% | +50% | -66.67% | -81.63% | -70.61% | -77.61% |
| 2014 | 2013 | 2012 | |||||||||
| -38.36% | -40.52% | -18.75% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0% | -57.14% | +33.33% | +0% | +0% | -75.00% | +100% | -71.43% | |||||
| 2025 | -9.09% | -10.00% | -11.11% | +25% | -10.00% | +11.11% | +0% | -10.00% | +11.11% | -0% | -10.00% | -22.22% | -36.36% |
| 2024 | +0% | +10% | +90.91% | -19.05% | -11.76% | -6.67% | +14.29% | -0% | +12.50% | -11.11% | -6.25% | -26.67% | +10% |
| 2023 | +50% | +0% | -11.11% | -12.50% | +57.14% | +36.36% | -13.33% | -30.77% | +0% | -11.11% | +12.50% | +11.11% | +66.67% |
| 2022 | -15.79% | -12.50% | +0% | -14.29% | -8.33% | +18.18% | -15.38% | +0% | -9.09% | +10% | -18.18% | -33.33% | -68.42% |
| 2021 | +136.36% | +19.23% | -22.58% | +12.50% | +37.04% | +97.30% | -52.05% | +25.71% | -13.64% | -21.05% | -13.33% | -26.92% | +72.73% |
| 2020 | -5.56% | -17.65% | +7.14% | +66.67% | +12% | +57.14% | -0% | -31.82% | -6.67% | -39.29% | +17.65% | -45.00% | -38.89% |
| 2019 | +25% | +13.33% | +141.18% | -14.63% | -14.29% | -0% | -20.00% | -4.17% | -0% | -21.74% | -11.11% | +12.50% | +50% |
| 2018 | +208.33% | -17.12% | -31.52% | -19.05% | -27.45% | -32.43% | +4% | -3.85% | -20.00% | -25.00% | -13.33% | -7.69% | -66.67% |
| 2017 | -3.06% | +5.26% | -47.00% | -22.64% | -23.17% | +9.52% | -31.88% | +27.66% | +23.33% | -21.62% | -20.69% | -21.74% | -81.63% |
Drawdown analysis of Atossa Therapeutics (ATOS)
The maximum drawdown for the ATOS was -100.00%, occurring on Jun 22, 2026. This drawdown has not yet recovered.
The current ATOS drawdown is -99.99%.
Since Nov 8, 2012 ATOS has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 3 times
- 10% or more: 4 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -100.00% | Mar 19, 2013 | 3334 | Jun 22, 2026 | Ongoing | Ongoing | Ongoing |
| -23.85% | Dec 11, 2012 | 14 | Jan 2, 2013 | 18 | Jan 29, 2013 | 32 |
| -20.00% | Feb 12, 2013 | 9 | Feb 26, 2013 | 14 | Mar 18, 2013 | 23 |
| -15.62% | Nov 8, 2012 | 1 | Nov 9, 2012 | 20 | Dec 10, 2012 | 21 |
| -4.85% | Feb 1, 2013 | 1 | Feb 4, 2013 | 1 | Feb 5, 2013 | 2 |
| -1.89% | Jan 29, 2013 | 1 | Jan 30, 2013 | 1 | Jan 31, 2013 | 2 |